Your session is about to expire
← Back to Search
Neurotoxin
Botox for Overactive Bladder
N/A
Recruiting
Led By Jennifer Anger, MD, MPH
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 21 years or older
Female
Timeline
Screening 3 weeks
Treatment Varies
Follow Up about 10 months
Awards & highlights
Study Summary
This trial will use MRI and urodynamics to study how botulinum toxin alleviates symptoms of overactive bladder in women who haven't responded to other treatments.
Who is the study for?
This trial is for women aged 21 or older who have overactive bladder symptoms that haven't improved with medication. Participants must be able to give informed consent and should not be claustrophobic, as the study involves MRI technology.Check my eligibility
What is being tested?
The study tests how well botulinum toxin (Botox) works in treating overactive bladder when its effects are monitored using a special type of MRI called cineMRI combined with urodynamics. This aims to understand Botox's impact on bladder function.See study design
What are the potential side effects?
While the side effects specific to this trial aren't listed, common side effects of Botox may include urinary tract infections, painful urination, inability to empty your bladder on your own, and localized pain where the injection was given.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 21 years old or older.
Select...
I am female.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ about 10 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~about 10 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Time-resolved views by CineMRI with urodynamics on overactive bladder physiology
Other outcome measures
Improvement in overactive bladder symptoms by smooth muscle paralysis via botulinum toxin injection (100U)
Trial Design
1Treatment groups
Experimental Treatment
Group I: Arm 1Experimental Treatment1 Intervention
Botulinum toxin and cineMRI-UDS
Find a Location
Who is running the clinical trial?
Cedars-Sinai Medical CenterLead Sponsor
502 Previous Clinical Trials
165,683 Total Patients Enrolled
Jennifer Anger, MD, MPHPrincipal InvestigatorCedars-Sinai Medical Center
2 Previous Clinical Trials
300 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 21 years old.I am 21 years old or older.I am female.I frequently feel a strong urge to urinate.I am unable to understand and agree to the study's details.You are afraid of being in small or enclosed spaces.
Research Study Groups:
This trial has the following groups:- Group 1: Arm 1
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment of participants still open for this experiment?
"Clinicaltrials.gov has verifiable information that this study is still recruiting patients; the investigation was initially published on December 1st 2014 and underwent its most recent amendment in July 17th 2018."
Answered by AI
What is the expected total of participants in this clinical trial?
"Affirmative. Based on the data hosted by clinicaltrials.gov, this trial is seeking participants at present. The posting was first created on December 1st 2014 and last revised on July 17th 2018 with a goal to enroll 10 patients from a single medical centre."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger